Efficacy News and Research

RSS
Shire to commence two Vyvanse and Concerta Phase 4 comparison trials for ADHD

Shire to commence two Vyvanse and Concerta Phase 4 comparison trials for ADHD

Bevacizumab drug improves cardiac output in patients with HHT

Bevacizumab drug improves cardiac output in patients with HHT

AcelRx initiates ARX-01 Phase 3 study for treatment of post-operative pain

AcelRx initiates ARX-01 Phase 3 study for treatment of post-operative pain

MTPC, Medicago partner to develop and commercialize three new vaccines

MTPC, Medicago partner to develop and commercialize three new vaccines

Santarus fourth quarter total revenues increase 65% to $42.6M

Santarus fourth quarter total revenues increase 65% to $42.6M

Merck announces success of pill against ragweed allergy

Merck announces success of pill against ragweed allergy

Zalicus completes reformulated Z160 Phase 1 clinical trial for pain

Zalicus completes reformulated Z160 Phase 1 clinical trial for pain

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Bill Gates meets MTBVAC TB vaccine researchers in Spain

Bill Gates meets MTBVAC TB vaccine researchers in Spain

Anthera continues Phase 2b PEARL-SC clinical study in SLE patients

Anthera continues Phase 2b PEARL-SC clinical study in SLE patients

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

BioLineRx granted Israeli approval for BL-7040 Phase II clinical trial for IBD

BioLineRx granted Israeli approval for BL-7040 Phase II clinical trial for IBD

Researchers identify mechanism with which cancer cells protect themselves against damage

Researchers identify mechanism with which cancer cells protect themselves against damage

Concert, Fast Forward partner to advance new approach to treat spasticity and pain in MS

Concert, Fast Forward partner to advance new approach to treat spasticity and pain in MS

KYTHERA commences two ATX-101 Phase III trials for reduction of submental fat

KYTHERA commences two ATX-101 Phase III trials for reduction of submental fat

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Meda announces positive results from three MP29-02 studies on allergic rhinitis

SK Biopharmaceuticals' YKP3089 receives Korea Drug Development Fund

SK Biopharmaceuticals' YKP3089 receives Korea Drug Development Fund

Long-term data from Baxter's HyQ clinical study on PI

Long-term data from Baxter's HyQ clinical study on PI

HNSF, AAO publish new guideline on sudden hearing loss

HNSF, AAO publish new guideline on sudden hearing loss

Ekso Bionics, Kessler Foundation partner to test commercial robotic exoskeleton

Ekso Bionics, Kessler Foundation partner to test commercial robotic exoskeleton

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.